<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Pan D</submitter><funding>National Natural Science Foundation of China</funding><funding>International Cooperation Program of National Natural Science Foundation of China</funding><funding>International  Cooperation Program of National Natural Science Foundation of China</funding><funding>Key Program of Natural Science Foundation of Tianjin</funding><pagination>172</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC8353762</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>18(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Traumatic spinal cord injury (SCI) is a severely disabling disease that leads to loss of sensation, motor, and autonomic function. As exosomes have great potential in diagnosis, prognosis, and treatment of SCI because of their ability to easily cross the blood-brain barrier, the function of Schwann cell-derived exosomes (SCDEs) is still largely unknown.&lt;h4>Methods&lt;/h4>A T10 spinal cord contusion was established in adult female mice. SCDEs were injected into the tail veins of mice three times a week for 4 weeks after the induction of SCI, and the control group was injected with PBS. High-resolution transmission electron microscope and western blot were used to characterize the SCDEs. Toll-like receptor 2 (TLR2) expression on astrocytes, chondroitin sulfate proteoglycans (</pubmed_abstract><journal>Journal of neuroinflammation</journal><pubmed_title>Increasing toll-like receptor 2 on astrocytes induced by Schwann cell-derived exosomes promotes recovery by inhibiting CSPGs deposition after spinal cord injury.</pubmed_title><pmcid>PMC8353762</pmcid><funding_grant_id>19JCZDJC36300</funding_grant_id><funding_grant_id>81772342</funding_grant_id><funding_grant_id>82072439</funding_grant_id><funding_grant_id>81620108018</funding_grant_id><pubmed_authors>Lv Z</pubmed_authors><pubmed_authors>Li Y</pubmed_authors><pubmed_authors>Pan D</pubmed_authors><pubmed_authors>Huang Y</pubmed_authors><pubmed_authors>Shao Y</pubmed_authors><pubmed_authors>Feng S</pubmed_authors><pubmed_authors>Yang F</pubmed_authors><pubmed_authors>Ning G</pubmed_authors><pubmed_authors>Zhu S</pubmed_authors></additional><is_claimable>false</is_claimable><name>Increasing toll-like receptor 2 on astrocytes induced by Schwann cell-derived exosomes promotes recovery by inhibiting CSPGs deposition after spinal cord injury.</name><description>&lt;h4>Background&lt;/h4>Traumatic spinal cord injury (SCI) is a severely disabling disease that leads to loss of sensation, motor, and autonomic function. As exosomes have great potential in diagnosis, prognosis, and treatment of SCI because of their ability to easily cross the blood-brain barrier, the function of Schwann cell-derived exosomes (SCDEs) is still largely unknown.&lt;h4>Methods&lt;/h4>A T10 spinal cord contusion was established in adult female mice. SCDEs were injected into the tail veins of mice three times a week for 4 weeks after the induction of SCI, and the control group was injected with PBS. High-resolution transmission electron microscope and western blot were used to characterize the SCDEs. Toll-like receptor 2 (TLR2) expression on astrocytes, chondroitin sulfate proteoglycans (</description><dates><release>2021-01-01T00:00:00Z</release><publication>2021 Aug</publication><modification>2025-04-04T13:51:06.6Z</modification><creation>2022-02-11T06:41:19.691Z</creation></dates><accession>S-EPMC8353762</accession><cross_references><pubmed>34372877</pubmed><doi>10.1186/s12974-021-02215-x</doi></cross_references></HashMap>